TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
First Patient Dosed in Phase 1 Study
Study seeks to further develop a new compound to treat patients with tuberculosis
